There is a gap of knowledge about the clinical and pathophysiological implications resulting
from the interaction between primary hyperlipidemias and type 2 diabetes (T2D). Most of the …

Background: Elevated Lp (a)(Lipoprotein (a)) levels are associated with coronary artery
disease (CAD), ischemic stroke (IS), and calcific aortic valve stenosis (CAVS). Studies …

Although Lp (a) contributes to the development of cardiovascular disease in patients with
diabetes, few trials have investigated the benefits of reducing Lp (a) within this patient …

Purpose While low density lipoprotein cholesterol (LDL-C) remains a key contributor of
atherosclerotic cardiovascular disease (ASCVD), additional risk factors identified through …

Background: The remnant-like particle cholesterol (RLP-C) has been demonstrated to be
associated with residual cardiovascular risk. The meta-analysis aimed to evaluate the …

To assess the determinants of lipid parameters in primary care patients without diagnosed
cardiovascular disease (CVD), a cross-sectional study was conducted during 2018–2019 …

Background: Lp (a)(lipoprotein [a]) is a highly atherogenic lipoprotein subfraction that may
contribute to polygenic risk of coronary artery disease (CAD), but the extent of this …

Abstract Lipoprotein (a)[Lp (a)] concentrations are regulated by the LPA gene mainly via the
large kringle IV-type 2 (KIV-2) copy number variation and multiple causal variants. Early …

Chronic systemic inflammation is associated with an increased risk of cardiovascular
disease in an environment of low low-density lipoprotein (LDL) and low total cholesterol and …

Bile acids (BA) play an important role in cholesterol metabolism and possess further
beneficial metabolic effects as signalling molecules. Blocking the hepatocellular uptake of …